Edition:
United Kingdom

Odonate Therapeutics Announces Financial Results For The Three Months Ended March 31, 2019


Thursday, 25 Apr 2019 

April 25 (Reuters) - Odonate Therapeutics Inc ::ODONATE THERAPEUTICS ANNOUNCES FINANCIAL RESULTS FOR THE THREE MONTHS ENDED MARCH 31, 2019.QUARTERLY LOSS PER SHARE $1.16.AS OF MARCH 31, 2019, ODONATE HAD $112.1 MILLION IN CASH, COMPARED TO $139.1 MILLION AS OF DECEMBER 31, 2018. 

Company Quote

28.36
-0.68 -2.34%
13 Sep 2019